| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |